Adenosine labels and packages: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Adenosine}} {{CMG}}; {{AE}} {{AZ}} == Labels and Packages== {| |600px|thumb |} {| |File:Adenosine4 ml cartoon.JPG|600px|th...")
 
No edit summary
Line 6: Line 6:


{|
{|
|[[File:Adenosine2 ml cartoon.JPG|600px|thumb]]
|[[File:Adenosine2 ml cartoon.JPG|400px|thumb]]


|}
|}


{|
{|
|[[File:Adenosine4 ml cartoon.JPG|600px|thumb]]
|[[File:Adenosine4 ml cartoon.JPG|400px|thumb]]


|}<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = ADENOCARD (ADENOSINE) SOLUTION [ASTELLAS PHARMA US, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f0e32589-dad9-4887-8481-bcf7f6618466 | publisher =  | date =  | accessdate = }}</ref>
|}<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = ADENOCARD (ADENOSINE) SOLUTION [ASTELLAS PHARMA US, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f0e32589-dad9-4887-8481-bcf7f6618466 | publisher =  | date =  | accessdate = }}</ref>

Revision as of 18:23, 11 March 2014

Adenosine
ADENOCARD®, ADENOSCAN® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Labels and Packages
Clinical Trials on Adenosine
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Labels and Packages

[1]

References

  1. "ADENOCARD (ADENOSINE) SOLUTION [ASTELLAS PHARMA US, INC.]".

Adapted from the FDA Package Insert.